NS Partners’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.2M | Sell |
45,873
-25,614
| -36% | -$11.2M | 0.78% | 40 |
|
|
2026
Q1 | $33M | Sell |
71,487
-768
| -1% | -$389K | 1.48% | 23 |
|
|
2025
Q4 | $40.9M | Buy |
72,255
+49
| +0.1% | +$26.1K | 1.6% | 15 |
|
|
2025
Q3 | $32.3M | Buy |
72,206
+9
| +0% | +$4.32K | 1.25% | 21 |
|
|
2025
Q2 | $39.2M | Sell |
72,197
-1,598
| -2% | -$836K | 1.6% | 16 |
|
|
2025
Q1 | $36.5M | Buy |
73,795
+1,241
| +2% | +$686K | 1.61% | 20 |
|
|
2024
Q4 | $37.9M | Sell |
72,554
-964
| -1% | -$502K | 1.57% | 19 |
|
|
2024
Q3 | $36.1M | Buy |
73,518
+1,632
| +2% | +$760K | 1.52% | 22 |
|
|
2024
Q2 | $32M | Buy |
71,886
+312
| +0.4% | +$124K | 1.45% | 22 |
|
|
2024
Q1 | $28.6M | Buy |
71,574
+566
| +0.8% | +$214K | 1.32% | 26 |
|
|
2023
Q4 | $24M | Buy |
71,008
+473
| +0.7% | +$141K | 1.16% | 32 |
|
|
2023
Q3 | $20.6M | Sell |
70,535
-406
| -0.6% | -$127K | 1.11% | 34 |
|
|
2023
Q2 | $24.3M | Sell |
70,941
-504
| -0.7% | -$152K | 1.28% | 31 |
|
|
2023
Q1 | $18.3M | Buy |
71,445
+74
| +0.1% | +$18.2K | 1.03% | 46 |
|
|
2022
Q4 | $18.9M | Buy |
71,371
+371
| +0.5% | +$90.5K | 1.14% | 40 |
|
|
2022
Q3 | $13.3M | Buy |
71,000
+2,879
| +4% | +$618K | 0.86% | 52 |
|
|
2022
Q2 | $13.7M | Buy |
68,121
+569
| +0.8% | +$133K | 0.83% | 50 |
|
|
2022
Q1 | $20.4M | Sell |
67,552
-3,040
| -4% | -$888K | 1.09% | 37 |
|
|
2021
Q4 | $25.4M | Buy |
70,592
+359
| +0.5% | +$124K | 1.19% | 33 |
|
|
2021
Q3 | $23.3M | Buy |
70,233
+183
| +0.3% | +$61.5K | 1.19% | 35 |
|
|
2021
Q2 | $21.5M | Buy |
70,050
+45
| +0.1% | +$12.6K | 1.13% | 35 |
|
|
2021
Q1 | $17.2M | Sell |
70,005
-1,986
| -3% | -$500K | 1% | 38 |
|
|
2020
Q4 | $19.6M | Buy |
71,991
+180
| +0.3% | +$44.7K | 1.15% | 34 |
|
|
2020
Q3 | $17M | Buy |
71,811
+8,136
| +13% | +$1.83M | 1.12% | 39 |
|
|
2020
Q2 | $12.1M | Buy |
63,675
+21,813
| +52% | +$3.91M | 0.89% | 48 |
|
|
2020
Q1 | $6.91M | Buy |
41,862
+6,264
| +18% | +$1.15M | 0.64% | 56 |
|
|
2019
Q4 | $7.02M | Buy |
35,598
+168
| +0.5% | +$31.5K | 0.56% | 60 |
|
|
2019
Q3 | $6.38M | Buy |
35,430
+561
| +2% | +$97K | 0.57% | 59 |
|
|
2019
Q2 | $6.1M | Buy |
+34,869
| New | +$5.97M | 0.56% | 61 |
|
Other funds holding ISRG
NS Partners's ISRG Position: Q2 2026 in Review
NS Partners reduced its Intuitive Surgical (ISRG) stake by 36% in Q2 2026, selling an estimated $11.2M and leaving 45,873 shares worth $18.2M. The position accounts for 0.78% of the portfolio, ranked #40.
NS Partners first reported a position in ISRG in Q2 2019 and has held it in 29 quarters since. The position peaked at $40.9M in Q4 2025. 2,260 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- NS Partners held 45,873 shares of Intuitive Surgical worth $18.2M as of Q2 2026.
- NS Partners sold 25,614 Intuitive Surgical shares in Q2 2026, an estimated $11.2M.
- Intuitive Surgical made up 0.78% of NS Partners's portfolio in Q2 2026, its #40 holding.
- NS Partners first reported a position in Intuitive Surgical in Q2 2019 and has held it in 29 quarters since.
- NS Partners's Intuitive Surgical position peaked at $40.9M in Q4 2025.
- 2,260 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on NS Partners's 13F filing for Q2 2026, filed 13 Aug 2026.